SC-10914 (SC10914) is a novel and highly potent PARP inhibitor (IC50 = 7.87 nM) with anticancer activity. It has favorabler pharmacokinetic profiles and thus has the potential to be used for the treatment of treatment of BRCA1/2 deficient cancers.

纯度：≥98%

CAS：76985-08-5 (free base)